ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Michael Friedman to Retire as CEO of City of Hope

March 1, 2013

In Brief: Schmidt Of Germany UICC President Elect David Korn Appointed New Dean At Stanford

October 19, 1984

NCI High School Summer Program Called Successful

October 19, 1990

Funding Opportunities.

May 10, 2002

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

May 24, 2002